From Yahoo Finance: 2025-06-18 05:22:00

STERIS plc (STE) is a $23.7 billion company providing infection prevention products and services in healthcare, AST, and life sciences. While STE shares dropped 6.2% from the 52-week high, they have outperformed the Health Care Select Sector SPDR Fund. STE has gained 15.3% YTD and is trading above key moving averages.

After releasing Q4 earnings, STE saw a 8.5% jump in shares, with revenue reaching $1.5 billion and adjusted EPS at $2.74. Key rival AdaptHealth Corp. (AHCO) has lagged behind STE with a 24.6% decrease in stock over the past 52 weeks. Eight analysts rate STE as a “Moderate Buy” with a price target of $272.14, implying a 14.8% upside potential.

Read more: Is STE Outperforming the Healthcare Sector?